Publikation
Phase 2 trial of single-agent everolimus in chemotherapy-naive patients with castration-resistant prostate cancer (SAKK 08/08)
Wissenschaftlicher Artikel/Review - 06.04.2013
Templeton Arnoud, Schiess Ralph, Wild Peter J, Rüschoff Jan H, Thalmann George, Dietrich Pierre-Yves, Aebersold Ruedi, Klingbiel Dirk, Gillessen Sommer Silke, Müller Beat, Winterhalder Ralph, Stenner Frank, Dutoit Valérie, Cathomas Richard, Rothermundt Christian, Bärtschi Daniela, Dröge Cornelia, Gautschi Oliver, Borner Markus, Fechter Eva, Swiss Group for Clinical Cancer Research (SAKK)
Templeton, Arnoud
Dutoit, Valérie
Cathomas, Richard
Rothermundt, Christian
Leitender ArztLeitung Ambulatorium St.Gallen & Rorschach
Medizinische Onkologie und Hämatologie · Dept. I